Details of the Drug Reposition

General Information of This Drug (ID: DM4F8AU)

Drug Name
HuCART-meso cells   DM4F8AU
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pediatric cancer DISWYLB3 2A00-2F9Z Phase 1 [1]
Pancreatic cancer DISJC981 2C10 Phase 1 [1]
Lymphatic disease DIS57XO9 BD9Z Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03323944) CAR T Cell Immunotherapy for Pancreatic Cancer